Therefore, the results of this study demonstrated that the detection of α-synuclein in saliva could be used as a promising and easily accessible biomarker for PD but not for a differential diagnosis between PD and PSP [43]. This evidence concerns the gene SNCA and supranuclear palsy, progressive, 1.